Human and murine interleukin 23 receptors are novel substrates for a disintegrin and metalloproteases ADAM10 and ADAM17

Journal of Biological Chemistry

Volumn 291, Issue 20, 2016, Pages 10551-10561

  Franke, Manuel ^a   Schröder, Jutta ^a   Monhasery, Niloufar ^a   Ackfeld, Theresa ^a   Hummel, Thorben M ^a   Rabe, Björn ^b   Garbers, Christoph ^b   Becker Pauly, Christoph ^b   Floss, Doreen M ^a   Scheller, Jürgen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES;

AMINO ACID RESIDUES; AUTOIMMUNE DISEASE; BINDING ACTIVITIES; CRITICAL DETERMINANT; ECTODOMAIN SHEDDING; INTERACTION STUDIES; PHORBOL 12 MYRISTATE 13 ACETATES; SELECTIVE INHIBITORS;

IMMUNE SYSTEM;

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; AMINO ACID; INTERLEUKIN 23 RECEPTOR; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN ADAM17; UNCLASSIFIED DRUG; ADAM10 PROTEIN, HUMAN; ADAM10 PROTEIN, MOUSE; IL23R PROTEIN, HUMAN; INTERLEUKIN 23; INTERLEUKIN RECEPTOR; INTERLEUKIN-23 RECEPTOR, MOUSE; MEMBRANE PROTEIN; SECRETASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ARTICLE; BINDING SITE; COS 7 CELL LINE; HEK293 CELL LINE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; ALTERNATIVE RNA SPLICING; ANIMAL; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HALF LIFE TIME; MEMBRANE MICROPARTICLE; METABOLISM; SOLUBILITY;

ADAM10 PROTEIN; ADAM17 PROTEIN; ALTERNATIVE SPLICING; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL-DERIVED MICROPARTICLES; HALF-LIFE; HEK293 CELLS; HUMANS; INTERLEUKIN-23; MEMBRANE PROTEINS; MICE; RECEPTORS, INTERLEUKIN; SOLUBILITY; SUBSTRATE SPECIFICITY; TETRADECANOYLPHORBOL ACETATE;

EID: 84969217511     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.710541     Document Type: Article

References (28)

1. Floss, D. M., Schröder, J., Franke, M., and Scheller, J. (2015) Insights into IL-23 biology: from structure to function. Cytokine Growth Factor Rev. 26, 569-578
2. Ouyang, W., Kolls, J. K., and Zheng, Y. (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467
3. Cosmi, L., Maggi, L., Santarlasci, V., Liotta, F., and Annunziato, F. (2014)T helper cells plasticity in inflammation. Cytometry A 85, 36-42
4. Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C. Y., Gately, M. K., and Gubler, U. (1996) A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U.S.A. 93, 14002-14007
5. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., To, W., Wagner, J., O'Farrell, A. M., McClanahan, T., Zurawski, S., et al. (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708
6. Schröder, J., Moll, J. M., Baran, P., Grötzinger, J., Scheller, J., and Floss, D. M. (2015) Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor β1 via site II and induces p19/interleukin 23 receptor interaction via site III. J. Biol. Chem. 290, 359-370
7. Floss, D. M., Mrotzek, S., Klöcker, T., Schröder, J., Grötzinger, J., Rose-John, S., and Scheller, J. (2013) Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor. J. Biol. Chem. 288, 19386-19400
8. Edwards, D. R., Handsley, M. M., and Pennington, C. J. (2008) TheADAM metalloproteinases. Mol. Aspects Med. 29, 258-289
9. Garbers, C., Jänner, N., Chalaris, A., Moss, M. L., Floss, D. M., Meyer, D., Koch-Nolte, F., Rose-John, S., and Scheller, J. (2011) Species specificity of ADAM10 and ADAM7 in IL-6 transsignaling and novel role of ADAM10 in inducible IL-6R shedding. J. Biol. Chem. 286, 14804-14811
10. Le Gall, S. M., Bobé, P., Reiss, K., Horiuchi, K., Niu, X. D., Lundell, D., Gibb, D. R., Conrad, D., Saftig, P., and Blobel, C. P. (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor α, Lselectin, and tumor necrosis factor α. Mol. Biol. Cell 20, 1785-1794
11. Scheller, J., Chalaris, A., Garbers, C., and Rose-John, S. (2011) ADAM17: a molecular switch controlling inflammatory and regenerative responses. Trends Immunol 32, 380-387
12. Kan, S. H., Mancini, G., and Gallagher, G. (2008) Identification and characterization of multiple splice forms of the human interleukin-23 receptor α chain in mitogen-activated leukocytes. Genes Immun 9, 631-639
13. Mancini, G., Kan, S. H., and Gallagher, G. (2008) A novel insertion variant of the human IL-23 receptor-α chain transcript. Genes Immun 9, 566-569
14. Zhang, X. Y., Zhang, H. J., Zhang, Y., Fu, Y. J., He, J., Zhu, L. P., Wang, S. H., and Liu, L. (2006) Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 57, 934-943
15. Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P., Kallen, K. J., Wollmer, A., Grötzinger, J., and Rose-John, S., (1997) A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15, 142-145
16. Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V., Kallen, K. J., Rose-John, S., and Ludwig, A. (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102, 1186-1195
17. de Paus, R. A., van de Wetering, D., van Dissel, J. T., and van de Vosse, E. (2008) IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants. Mol. Immunol. 45, 3889-3895
18. van de Vosse, E., de Paus, R. A., van Dissel, J. T., and Ottenhoff, T. H. (2005) Molecular complementation of IL-12Rβ1 deficiency reveals functional differences between IL-12Rβ1 alleles including partial IL-12Rβ1 deficiency. Hum. Mol. Genet. 14, 3847-3855
19. Althoff, K., Reddy, P., Voltz, N., Rose-John, S., and Müllberg, J. (2000) Contribution of the amino acid sequence at the cleavage site to the cleavage pattern of transmembrane proteins. Eur. J. Biochem. 267, 2624-2631
20. Suthaus, J., Tillmann, A., Lorenzen, I., Bulanova, E., Rose-John, S., and Scheller, J. (2010) Forced homo-and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth. Mol. Biol. Cell 21, 2797-2807
21. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., Zonin, F., Vaisberg, E., Churakova, T., Liu, M., Gorman, D., et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725
22. Rothbauer, U., Zolghadr, K., Muyldermans, S., Schepers, A., Cardoso, M. C., and Leonhardt, H. (2008) A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol. Cell. Proteomics 7, 282-289
23. Garbers, C., Monhasery, N., Aparicio-Siegmund, S., Lokau, J., Baran, P., Nowell, M. A., Jones, S. A., Rose-John, S., and Scheller, J. (2014) The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases. Biochim. Biophys. Acta 1842, 1485-1494
24. Tucher, J., Linke, D., Koudelka, T., Cassidy, L., Tredup, C., Wichert, R., Pietrzik, C., Becker-Pauly, C., and Tholey, A. (2014) LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. J. Proteome Res. 13, 2205-2214
25. Ngiow, S. F., Teng, M. W., and Smyth, M. J. (2013) A balance of interleukin-12 and-23 in cancer. Trends Immunol 34, 548-555
26. Guo, W., Luo, C., Wang, C., Zhu, Y., Wang, X., Gao, X., and Yao, W. (2012) Protection against Th17 cells differentiation by an interleukin-23 receptor cytokine-binding homology region. PLoS One 7, e45625
27. Yu, R. Y., and Gallagher, G. (2010) A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells. J. Immunol. 185, 7302-7308
28. Cho, M. L., Kang, J. W., Moon, Y. M., Nam, H. J., Jhun, J. Y., Heo, S. B., Jin, H. T., Min, S. Y., Ju, J. H., Park, K. S., Cho, Y. G., Yoon, C. H., Park, S. H., Sung, Y. C., and Kim, H. Y. (2006) STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652-5661